2 May 2024

Jan Nilsson

Born: 1949
Nationality: Swedish

Education and professional experience: Jan Nilsson holds a M.Sc. from the University of Gothenburg and an MBA from Uppsala University. Jan has long and broad experience from both large pharmaceutical companies and biotech firms. He has been active in several different therapeutic areas in the pharmaceutical industry and has, in addition to participating in the product development process, also had key roles in the launch, sales and marketing of established international brands. Jan also has solid management background, having served as CEO in both public and private companies.

Other assignments: Jan is currently Chairman of the Board of CCRM Nordic AB (svb) and a member of the Board of Directors of Aptahem AB (publ), CarryGenes Therapeutics AB and Urbicum Ledningskonsult AB.

Independent in relation to the Company and its management as well as in relation to the Company’s major shareholders.
Shareholding in the Company: No shares